文章詳目資料

藥物食品檢驗局調查研究年報

  • 加入收藏
  • 下載文章
篇名 鎮咳祛痰劑之品質監測
卷期 25
並列篇名 Survey on the Quality of Oral Preparations of antitussives and Expectorants in Taiwan
作者 黃俐嘉陳玉盆黃明權鄒玫君
頁次 11-15
關鍵字 AntitussiveExpectorantsAmbroxol hydrochlorideBromhexine hydrochlorideEprazinone hydrochlorideSurveyTSCI
出刊日期 200710

中文摘要

為瞭解臺灣地區現階段市售鎮咳袪痰劑(Ambroxol hydrochloride、Bromhexine hydrochloride、Eprazinone hydrochloride)口服固型製劑之品質狀況,經函請北、高兩市及各縣市衛生局,於民國95年1月至6月間,赴轄區內醫院診所、藥局、藥廠及代理商抽驗市售檢體,抽驗檢體中Ambroxol hydrochloride計32件、Bromhexine hydrochloride計25件、Eprazinone hydrochloride計21件,共計78件,其中國產品76件,輸入品2件。參照中華藥典第五版之檢驗規格、方法及本局常用藥物化粧品檢驗方法專輯進行一般檢查、鑑別及含量測定等重點項目檢驗及依原廠規格判定,結果1件(含Eprazinone hydrochloride成分)品質檢驗不合格,不合格率1.28%,3件不判定(外觀與原申請之規格不一致),其他74件均合格,以上不符規定之產品,均已函送各地方衛生單位,依違反藥事法予以處理。本調查計畫之結果將提供作為藥政管理之參考。

英文摘要

To investigate the quality of oral solid dosage forms of antitussive and expectorant in current Taiwan market, a total of 78 samples of ambroxol hydrochloride (32), bromhexine hydrochloride (25) and eprazinone hydrochloride (21) drug products were collected from manufacturer, importer, hospital and pharmacy via county and/or city local health agencies during January to June 2006. Seventy-six products were local and 2 were imported. Analytical tests were performed on these products and conclusions were drawn based on the testing methods of Chinese Pharmacopeia V (Ch. P. V) and Bureau of Food and Drug and Analysis (BFDA) Analytical Methods for Drugs and Cosmetics. One (1.28%) antitussive failed to meet the requirement (eprazinone hydrochloride content), 3 antitussives and expectorants failed to conform to the specification of
appearances. Local health agencies were noticed of the test results for administrative sanctions of Phramaceutical Affairs Law (PAL) violation.

本卷期文章目次

相關文獻